nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Decreased spindle microtubules in CAMSAP2 KO cells. by Naoko Nishizawa (20536299)

Clinical Pharmacogenetics Implementation Consortium list of clinically actionable drugs with a pharmacogenomic indication and their associated genes. by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene SLCO1B1 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

PGx (number and percentage) associated adverse drug reactions and the prescribing prevalence (number and percentage) over a 20-year period (1993–2013). by Emma F. Magavern (20947928)

Subjects:

The biliary injuries and cholestasis are alleviated by the decreased pro-inflammatory activation of macrophages treated with InCsEVs. by Beibei Zhang (509356)

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). by Atefeh Fathi (7370876)

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2C19 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Number and percentage of adverse drug reaction reports associated with PREPARE drugs that have a pharmacogneomic indication for the gene CYP2D6 stratified by decade. by Emma F. Magavern (20947928)

Subjects:

Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

A frame from the video with behaviors annotated in a custom way. by Piotr Popik (292215)

A pair of RMVMR plots using two exposures presented for illustration. by Wes Spiller (13229484)

Decreased visceral nociceptive responses induced by <i>Toxoplasma gondii</i> chronic infection relies on peripheral opioid signaling. by Alexis Audibert (21213531)

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

“…Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

“…Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”

Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

“…Nonquantifiable increases in ABY-029 fluorescence in tumor and muscle were observed after <i>in vivo</i> blocking, while PAI produced the expected decrease in RA. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)